Health Care: Drugs

Enanta Pharmaceuticals Inc (ENTA: NASDAQ)

$40.29 0.72 | 1.82%
10/01/14 - 04:00 PM ET
Company Profile
Price and Volume
Recent Price 39.57
52 Week High 46.44
52 Week Low 18.31
Avg. Daily Vol. (Mil) 0.22
Beta (3 year) 0.00
Share Related Items
Mkt Cap (Mil) 735.31
Shares Out (Mil) 18.58
Float (Mil) 12.68
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 23.10
Current Ratio 26.20
LT Debt/ Equity 0.00
Total Debt / Equity 0.00
Valuation Ratios
Price Earnings 23.90
Price/Sales 15.83
Price/Book 4.81
Price/Cash Flow 19.60
Per Share Data
Earnings 1.65
Sales 2.50
Book Value 8.23
Cash Flow 2.02
Business Summary
Enanta Pharmaceuticals Inc is a research and development focused biotechnology company. It uses its robust chemistry-driven approach and drug discovery capabilities to create small molecule drugs in the infectious disease field.
General Information
500 Arsenal Street
Watertown, MA 02472
www.enanta.com
Industry : Drugs
Sector: Health Care
Employees: 44
CEO: Dr. Jay R. Luly
Short Interest
Current Month (Mil) 2.40
Previous Month (Mil) 2.39
Short Interest Ratio (Days) 8.50
Management Effectiveness
Return on Equity 22.90
Return on Assets 22.00
Return on Investments 22.90
Profitability
Gross Margin n.a.
EBIT Margin 37.50
Profit Margin 75.40

Portfolios with ENTA

Latest ENTA Headlines from TheStreet

More Financial News for ENTA

Press Releases for ENTA

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter